307. Rational Development of 12 Different AAV Serotypes as Scaffolds for Peptide Display

Molecular Therapy - United States
doi 10.1016/s1525-0016(16)33916-8
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

556. Comparative in Vitro Transduction Efficiency of AAV Vector Serotypes 1-9 in Different Cellular Models

Molecular Therapy
Molecular MedicineMolecular BiologyPharmacologyMedicineGeneticsDrug Discovery
2016English

AAV Natural Infection Induces Broad Cross-Neutralizing Antibody Responses to Multiple AAV Serotypes in Chimpanzees

Human gene therapy. Clinical development
Genetics
2016English

Comparison of AAV Serotypes for Gene Delivery to Dopaminergic Neurons in the Substantia Nigra

2011English

Rational Design of Nanofiber Scaffolds for Orthopedic Tissue Repair and Regeneration

Nanomedicine
DevelopmentMaterials ScienceNanoscienceMedicineBioengineeringNanotechnologyBiomedical Engineering
2013English

Single-Subunit Oligosaccharyltransferases of Trypanosoma Brucei Display Different and Predictable Peptide Acceptor Specificities.

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2017English

Engineering the PP7 Virus Capsid as a Peptide Display Platform

English

Models as Scaffolds for Understanding

2013English

Photocrosslinking of cDNA Display Molecules With Their Target Proteins as a New Strategy for Peptide Selection

Molecules
Organic ChemistryMolecular MedicineAnalytical ChemistryTheoretical ChemistryPharmaceutical ScienceMedicineDrug DiscoveryChemistryPhysical
2020English

Phage Display Screening of Therapeutic Peptide for Cancer Targeting and Therapy

Protein & Cell
BiochemistryBiotechnologyDrug DiscoveryCell BiologyMedicine
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy